Background Non Muscle mass Invasive Bladder Transitional Malignancy (NMIBC) and Muscle mass Invasive Bladder Transitional Malignancy (MIBC)/invasive have different gene profile and clinical program. been reported for invasive tumors. About 60% to 70% of NMIBC recur, and about 15% to 25% of individuals relapse with invasive bladder malignancy [4]. Histopathological stage and grade are currently… Continue reading Background Non Muscle mass Invasive Bladder Transitional Malignancy (NMIBC) and Muscle